Skip to main content

Advertisement

Table 1 Experimental protocol and basic characteristics in AICH patients (n = 8) and healthy controls (n = 4) group

From: Identification of novel biomarker and therapeutic target candidates for acute intracerebral hemorrhage by quantitative plasma proteomics

Block Tissue Disease or normal Patient number Age/gender District and hospital TMT labeling reagent ID TMT labeling code
1 1 Normal 1 66/F Nanjing 1 126
1 2 AICH 2 61/F Nanjing 1 127
1 4 AICH 3 65/F Nanjing 1 129
   Reference     1 131
2 6 Normal 4 60/M Nanjing 2 126
2 7 AICH 5 56/M Nanjing 2 127
2 9 AICH 6 58/M Nanjing 2 129
   Reference     2 131
3 11 Normal 7 71/M Zhenjiang 3 126
3 12 AICH 8 69/M Zhenjiang 3 127
3 14 AICH 9 66/M Zhenjiang 3 129
   Reference     3 131
4 16 Normal 10 56/F Zhenjiang 4 126
4 17 AICH 11 61/F Zhenjiang 4 127
4 19 AICH 12 57/F Zhenjiang 4 129
   Reference     4 131
  1. Reference represents a reference sample, i.e., a mixed sample of all plasma samples by internal standard method
  2. AICH acute intracerebral hemorrhage, F female, M male